Filing Details
- Accession Number:
- 0001209191-20-031000
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-20 18:07:15
- Reporting Period:
- 2020-05-18
- Accepted Time:
- 2020-05-20 18:07:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1564824 | Allakos Inc. | ALLK | Pharmaceutical Preparations (2834) | 454798831 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1674884 | A Peter Hudson | One Embarcadero Center Suite 3700 San Francisco CA 94111 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-05-18 | 4,549 | $71.13 | 6,989 | No | 4 | S | Indirect | By Hudson Capital LLC |
Common Stock | Disposition | 2020-05-18 | 6,989 | $72.33 | 0 | No | 4 | S | Indirect | By Hudson Capital LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Hudson Capital LLC |
No | 4 | S | Indirect | By Hudson Capital LLC |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,557,377 | Indirect | See Footnote |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.72 - $71.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.83 - $72.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- These shares are directly held by Alta Partners NextGen Fund I L.P. ("APNG I"). Alta Partners NextGen Fund I Management, LLC ("APNG I Management") is the general partner of APNG I. The Reporting Person is one of three managing directors of APNG I Management and, as such, has voting and investment control with respect to the shares held by APNG I. The Reporting Person disclaims beneficial ownership of all shares held by APNG I, except to the extent of his pecuniary interest therein.